Cruise stocks rally after FDA approval of Pfizer COVID-19 vaccine

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 97%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Cruise stocks among those rallying on first full COVID vaccine approval by FDA

Shares of cruise operators rallied Monday, as the Food and Drug Administration's full approval of the COVID-19 vaccine developed by Pfizer Inc. PFE, +2.92% and partner BioNTech SE BNTX, +8.77% boosted hopes for increased vaccination rates. Carnival Corp.'s stock CCL, +2.69% ran up 2.6%, Norwegian Cruise Line Holdings Ltd.

shares climbed 3.0% and Royal Caribbean Group GRP, -0.85% tacked on 1.1%. In comparison, the S&P 500 SPX, +0.96% advanced 0.9%. The companies have required its staff and guests on most of their cruises to be vaccinated. Acting FDA Commissioner Janet Woodcock said the FDA approval of the Pfizer-BioNTech vaccine"may now instill additional confidence to get vaccinated."

 

コメントありがとうございます。コメントは審査後に公開されます。
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 3. in JP

日本 最新ニュース, 日本 見出し